Tumor mutational burden (TMB) as a biomarker of response to immunotherapy in small cell lung cancer

Benzer Materyaller

• Predicting response to immunotherapy in advanced non-small-cell lung cancer using tumor mutational burden radiomic biomarker
  Yazar:: He, Bingxi, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Tumor mutation burden in lung cancer: a new predictive biomarker for immunotherapy or too soon to tell?
  Yazar:: Alexander, Mariam, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• Tumor Mutation Burden as a Biomarker in Resected Non–Small-Cell Lung Cancer
  Yazar:: Devarakonda, Siddhartha, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• Tumor Mutational Burden (TMB) as a Predictive Biomarker in Solid Tumors
  Yazar:: Sha, Dan, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Clinical Implications of Circulating Tumor DNA Tumor Mutational Burden (ctDNA TMB) in Non‐Small Cell Lung Cancer
  Yazar:: Chae, Young Kwang, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)